Afleveringen
-
Oncolytic virotherapy, an innovative approach leverages the natural ability of viruses to infect and kill tumor cells, offering a beacon of hope for patients battling cancer. Our journey through this domain uncovers the mechanisms of action of oncolytic viruses, explores representative examples, discusses strategic modifications and combinations with other therapies, addresses challenges, and reviews the clinical status of this cutting-edge treatment.
-
Zijn er afleveringen die ontbreken?
-
This video provides a comprehensive overview of lipid nanoparticle-based mRNA Vaccine development, detailing the technological timeline, the 2023 Nobel Prize-winning science behind the vaccines, and the specifics of COVID-19 vaccine candidates BNT162b2 and mRNA-1273. It also explores the advantages of liposomes in mRNA delivery, the intricate mechanisms of LNP-based vaccines, their therapeutic potential beyond COVID-19, and the rigorous development process. Creative Biolabs supports these innovations with specialized services and products, pushing the boundaries of medical science.
-
After decades of development and innovation, Creative Biolabs is committed to demonstrating our strong expertise and capabilities in the field of ribosome research, as well as expanding our research and service capabilities to multiple fields. This five-part video we will briefly introduce ribosome analysis technology, polysome profiling, ribosome profiling, ribosome affinity purification, and highlight the ribosome analysis solutions provided by Creative Biolabs.
-
Creative Biolabs integrates the latest scientific advances in exosomes and makes them into a podcast column. This episode introduces the exosome biogenesis and therapeutics knowledge.
-
Various barriers restrict the efficacy and/or prevent the widespread use of CAR-T cell therapies in these patients as well as in those with other diseases, particularly solid tumors. The evolution of CAR designs beyond conventional structures will be necessary to address these limitations and expand the use of CAR-T cells to a wider range of diseases. In this presentation, we discuss the progress in the development of innovative designs for new CAR-T cell products to increase and expand the clinical benefits of these treatments for patients with various cancers, and we explore the potential of CAR-T cell therapies in addressing diseases beyond cancer.
- Laat meer zien